Short Communication Open Access
Volume 3 | Issue 3 | DOI: https://doi.org/10.33696/AIDS.3.021
High Levels of Pre-Treatment HIV Drug Resistance in Zimbabwe: Is this a Threat to HIV/AIDS Control?
Vinie Kouamou1,*, Alan M McGregor1
- 1Unit of Internal Medicine, Faculty of Medicine and Health Sciences, University of Zimbabwe, Harare, Zimbabwe
Corresponding Author
Vinie Kouamou, kvinie2005@yahoo.fr
Received Date: April 06, 2021
Accepted Date: July 12, 2021
Kouamou V, McGregor AM. High Levels of Pre-Treatment HIV Drug Resistance in Zimbabwe: Is this a Threat to HIV/ AIDS Control?. J AIDS HIV Treat. 2021; 3(3): 42-45.
Copyright: © 2021 Kouamou V, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Recommended Articles
Black Women's Contribution to the HIV/AIDS Fight
After thousands of years of gender conflicts, the world now stands at the beginning of the feminine era, when women will rise to their proper standing, and the entire world will experience the harmony between men and women.
Toward Personalized Medicine for HIV/AIDS
In 2019, approximately 38 million people were infected with HIV worldwide [1]. Although there is still no cure that successfully eradicates the disease, combination antiretroviral therapy (cART) has improved to a point where undetectable viral loads have become achievable and HIV carriers often live almost normal lives with very substantially increased average life expectancies compared to historical data.
High Levels of Pre-Treatment HIV Drug Resistance in Zimbabwe: Is this a Threat to HIV/AIDS Control?
Zimbabwe is one of the countries in Southern Africa most affected by the Human Immunodeficiency Virus (HIV) epidemic. The country has the third highest HIV prevalence (12.5% among 15-49 years) in the region, with an estimated 1.4 million people living with HIV (PLHIV) to date.
Is Omicron Variant of COVID-19 Threatening Health Like Other Variants?
World health organization (WHO) designated the variant B.1.1.529 a variant of concern, named Omicron, as a fastspreading SARS-CoV-2 variant, on 26 November 2021 which started from Southern Africa. In addition to the new mutations (more than 30 mutations in the spike protein), Omicron also carries mutations similar to the alpha, beta, gamma, and delta variants of coronavirus, and is collectively known as the fifth most disturbing variant.
Perceptions and Knowledge of HIV/AIDS Among Black Women: An Exploratory Study
Black women in the United States face disproportionate rates of HIV/AIDS, with higher new infection rates and poorer health outcomes compared to other racial and gender groups. This study seeks to explore the perceptions and knowledge surrounding HIV/AIDS among Black women, to contribute to social work and public health knowledge. By identifying gaps in awareness and understanding of the distinct challenges Black women face regarding HIV/AIDS, this study provides valuable insight to inform the development of targeted interventions and policies to mitigate the impact of HIV/AIDS.